Cancer Diagnostics Market set to exceed USD 156 billion by 2024

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe.

Delaware, Selbyville - June 13, 2019 /MarketersMedia/ —

Cancer Diagnostics Market is set to exceed USD 156 billion by 2024; according to a new research report.
Increasing prevalence of cancer across the globe will be major driving factor for cancer diagnostics market. World Health Organization reported that cancer accounted for 8.8 million deaths in 2015 and was second leading cause of mortality. Unhealthy eating habits and changing lifestyle are further expected to boost prevalence in near future rendering significant positive impact on demand for better cancer diagnostic methods.

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe. Awareness and accessibility of cancer diagnostic products is lower in developing and underdeveloped regions. Private as well as government organizations are conducting awareness campaigns to educate people regarding the importance of early diagnosis. Such activities will influence industrial growth. For instance, Roche in partnership with China Cancer Rehabilitation Society (CCRS) conducted ‘Run for Her' campaign to raise awareness about mammography.

Request a sample of this premium report titled at https://www.marketstudyreport.com/request-a-sample/859978/?utm_source=MM-VHS

Recent technological advancements enabling quick and accurate diagnosis will propel cancer diagnostics market growth. Patients are receiving treatment specifically tailored with accordance to their genetic makeup with the help of diagnosis based of next generation sequencing and liquid biopsy. Advent of such technologies in near future will support industry growth.

However, prohibitive cost of diagnosis is hampering adoption rates in countries with low income levels. Risk of radiations exposure will further impede market growth over the forecast period.

Imaging application segment held largest revenue share in 2016 and the trend is expected to continue over the forecast timeframe owing to wide range of applicability of imaging devices to detect majority of cancer types. Advent of technologically advanced devices such as computed tomography and positron emission tomography devices will positively impact market growth. These devices provide high quality imaging at lower radiation dose. The side effects associated with usage of some conventional imaging devices due to radiation exposure will hinder segment growth to some extent.

The liver-lung cancer application segment accounted for majority of market share in 2016. The segment growth is largely supported by increasing prevalence due to changing dietary habits such as increasing alcohol consumption and smoking.

U.S. dominated cancer diagnostics market in 2016, due to high research and development activities focused at developing better diagnostic methods. Presence of leading medical technology and biotechnology firms coupled with high adoption rates of technologically superior diagnostic methods will drive the U.S. cancer diagnostics market growth over the forecast timeframe.

China cancer diagnostic market should witness robust growth due to presence of large patient pool and increasing disposable income. Growing awareness pertaining to benefits of early diagnosis will propel market growth. However, being a price sensitive market, inflated cost of some advanced diagnostic tests may limit regional growth to some extent.

Request a discount on standard prices of this premium report titled at https://www.marketstudyreport.com/check-for-discount/859978/?utm_source=MM-VHS

Some of the key industry players operating in global cancer diagnostics market are Sienna Cancer Diagnostics, F. Hoffmann-La Roche, Becton, Dickinson and Company, C.R. Bard, Qiagen, Abbott Laboratories, Hoffmann-La Roche, Thermo Fisher Scientific, Siemens AG, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips, Toshiba Medical Systems Corporation, Agilent Technologies, and Hologic. Industry players are trying to garner higher market share through various organic as well as inorganic growth strategies. The companies in the industry are further trying to develop cost-effective and accurate diagnostics methods to get a competitive edge.

Report Content

Chapter 1. Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition and forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Cancer diagnostics industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Application trends

2.1.3. Cancer type trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Cancer Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.2. Industry pitfalls & challenges

3.4. Growth potential analysis

3.4.1. By application

3.4.2. By cancer type

3.4.3. By end-use

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2016

3.7.1. Business overview

3.7.2. Revenue analysis

3.7.3. Product landscape

3.7.4. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Cancer Diagnostics Market, By Application

4.1. Global cancer diagnostics market share, by application, 2016 & 2024

4.2. Tumor biomarkers tests

4.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3. Imaging

4.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.1. Ultrasound and Radiology

4.3.1.1.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.2. Mammography

4.3.1.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.3. MRI Scan

4.3.1.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.4. PET Scan

4.3.1.4.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.5. CT Scan

4.3.1.5.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.6. SPECT & Others

4.3.1.6.1. Market estimates and forecast, by region, 2013 - 2024

4.4. Biopsy

4.4.1. Market estimates and forecast, by region, 2013 - 2024

4.5. Liquid Biopsy

4.5.1. Market estimates and forecast, by region, 2013 - 2024

4.6. Immunohistochemistry

4.6.1. Market estimates and forecast, by region, 2013 - 2024

4.7. In Situ Hybridization

4.7.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 5. Cancer Diagnostics Market, By Cancer type

5.1. Global cancer diagnostics market share, by cancer type, 2016 & 2024

5.2. Bladder Cancer

5.2.1. Market estimates and forecast, by region, 2013 - 2024

5.3. Breast Cancer

5.3.1. Market estimates and forecast, by region, 2013 - 2024

5.4. Colon and Rectal Cancer

5.4.1. Market estimates and forecast, by region, 2013 - 2024

5.5. Endometrial Cancer

5.5.1. Market estimates and forecast, by region, 2013 - 2024

5.6. Kidney Cancer

5.6.1. Market estimates and forecast, by region, 2013 - 2024

5.7. Leukemia

5.7.1. Market estimates and forecast, by region, 2013 - 2024

5.8. Liver-Lung Cancer

5.8.1. Market estimates and forecast, by region, 2013 - 2024

5.9. Melanoma

5.9.1. Market estimates and forecast, by region, 2013 - 2024

5.10. Non-Hodgkin Lymphoma

5.10.1. Market estimates and forecast, by region, 2013 - 2024

5.11. Pancreatic Cancer

5.11.1. Market estimates and forecast, by region, 2013 - 2024

5.12. Prostate Cancer

5.12.1. Market estimates and forecast, by region, 2013 - 2024

5.13. Thyroid Cancer

5.13.1. Market estimates and forecast, by region, 2013 - 2024

5.14. Others

5.14.1. Market estimates and forecast, by region, 2013 - 2024

Complete report titled at https://www.marketstudyreport.com/reports/cancer-diagnostics-market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com/

Source URL: https://marketersmedia.com/cancer-diagnostics-market-set-to-exceed-usd-156-billion-by-2024/523987

Source: MarketersMedia

Release ID: 523987

More News From travelstylo.com

Meghan launches clothing line to help jobless British women

Sep 16, 2019

LONDON — Meghan, the Duchess of Sussex, has launched a clothing line for a British charity that helps unemployed women find work. The wife of Prince Harry attended a reception at a John Lewis department store to showcase a collection of workwear and accessories she created with designer and friend Misha Nonoo. The line includes professional attire such as a blazer, tote bag and trousers. The launch came the day before London Fashion Week starts. The Smart Set collection supports Smart Works. Meghan is royal patron of the charity that provides women with training and interview clothes. Meghan said: "As...

The Blonds go over-the-top with the help of 'Moulin Rouge'

Sep 16, 2019

NEW YORK — Runway met Broadway when The Blonds took to the stage of the splashy musical "Moulin Rouge." With the help of Billy Porter, who performed two songs, the ever-theatrical design duo stuck to the musical's theme, focused on a cabaret, and stayed true to their risque style Monday for the New York Fashion Week show. After an opening number by performers from "Moulin Rouge," Phillipe Blond descended from the ceiling in a bedazzled jumpsuit, matching moto jacket and long, blond locks. They dressed models in corsets, bustier tops, lace catsuits (worn by men and women alike) and stiletto...

Papi's Back: David Ortiz throws out 1st pitch at Fenway

Sep 16, 2019

BOSTON — Former Red Sox slugger David Ortiz had a chance to thank his adoring fans at Fenway Park exactly three months after he was shot in the back while in his native Dominican Republic. In his first public appearance since June 9, when he was seriously injured in a Santo Domingo nightclub, Ortiz threw out the first pitch before the Red Sox played the New York Yankees. Ortiz took a microphone on the pitcher's mound and thanked the fans for their prayers and support after he threw the pitch to Jason Varitek, a catcher and teammate on Boston's 2004...

Oil drilling plan near Utah monument draws tribal opposition

Sep 16, 2019

SALT LAKE CITY — The U.S. government will allow oil and gas companies to make lease bids Monday on lands considered archaeologically sensitive near a national monument stretching across the Utah-Colorado border that houses sacred tribal sites. Included in the Bureau of Land Management's September oil and gas lease sale is about 47 square miles (122 square kilometers) of land north of Hovenweep National Monument, a group of prehistoric villages overlooking a canyon with connections to several indigenous tribes throughout the U.S. Southwest. The parcels for lease are about five to 20 miles (eight to 32 kilometers) north of the...

Like wine from France's Rhone Valley? Head to Walla Walla

Sep 16, 2019

WALLA WALLA, Wash. — Southeastern Washington has been producing high-quality wines for decades. But in the past five years, the wineries of the Walla Walla Valley have drawn international accolades for the reds produced from the unique soil just across the border in Oregon. Grapes grown in the six square miles known as The Rocks District of Milton-Freewater absorb the minerals from the distinctive basalt cobblestones, resulting in savory, earthy wines that have been compared to those of France's northern Rhone Valley. More than 120 wineries now dot the golden fields of the valley, and the resulting tourism has transformed...

Broaden News

Travel Stylo is an independent online travel website started by a group of friends who love traveling together. With Travel Stylo, you can travel with style.

Contact us: sales[at]travelstylo.com